Financial Ratios

ERIS LIFESCIENCES LTD.

NSE : ERISBSE : 540596ISIN CODE : INE406M01024Industry : Pharmaceuticals & DrugsHouse : Private
BSE841.200.15 (+0.02 %)
PREV CLOSE ( ) 841.05
OPEN PRICE ( ) 840.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 9808
TODAY'S LOW / HIGH ( )831.00 861.85
52 WK LOW / HIGH ( )557 971
NSE843.352.35 (+0.28 %)
PREV CLOSE( ) 841.00
OPEN PRICE ( ) 848.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 843.35 (14)
VOLUME 59652
TODAY'S LOW / HIGH( ) 832.00 862.15
52 WK LOW / HIGH ( )564.25 971.9
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)29.2730.6925.8221.4520.75
   CEPS(Rs)34.0234.4828.5924.7623.05
   DPS(Rs)7.356.015.502.870.00
   Book NAV/Share(Rs)163.18141.00115.7495.5183.97
   Tax Rate(%)8.909.029.859.998.47
Margin Ratios
   Core EBITDA Margin(%)36.8438.5836.7434.7937.23
   EBIT Margin(%)33.3936.7934.3131.9137.33
   Pre Tax Margin(%)31.8636.5534.2331.7234.78
   PAT Margin (%)29.0233.2630.8628.5531.83
   Cash Profit Margin (%)33.7437.3634.1732.9535.35
Performance Ratios
   ROA(%)17.3623.0223.3820.9920.79
   ROE(%)19.2523.9224.4523.7628.21
   ROCE(%)20.5426.4227.1224.7425.98
   Asset Turnover(x)0.600.690.760.740.65
   Sales/Fixed Asset(x)1.461.671.611.641.65
   Working Capital/Sales(x)5.113.034.073.403.46
Efficiency Ratios
   Fixed Capital/Sales(x)0.680.600.620.610.60
   Receivable days48.8136.5640.8938.7727.76
   Inventory Days19.7621.7720.9325.0726.92
   Payable days138.85167.72162.39183.06212.30
Valuation Parameters
   PER(x)19.5522.4523.4117.1831.04
   PCE(x)16.8119.9921.1414.8827.94
   Price/Book(x)3.514.895.223.867.67
   Yield(%)1.280.870.910.780.00
   EV/Net Sales(x)6.057.677.374.8410.07
   EV/Core EBITDA(x)15.4018.1719.1213.3324.64
   EV/EBIT(x)17.5820.1920.9715.1726.97
   EV/CE(x)3.114.675.033.606.44
   M Cap / Sales5.857.707.404.909.88
Growth Ratio
   Net Sales Growth(%)9.469.648.6813.8017.87
   Core EBITDA Growth(%)1.8520.0215.391.146.42
   EBIT Growth(%)-0.8118.4119.74-2.723.82
   PAT Growth(%)-4.6018.9920.372.06-2.82
   EPS Growth(%)-4.6418.8620.373.37-2.83
Financial Stability Ratios
   Total Debt/Equity(x)0.140.000.000.000.15
   Current Ratio(x)1.742.662.312.481.72
   Quick Ratio(x)1.602.362.082.161.51
   Interest Cover(x)21.85151.29416.49165.5114.61
   Total Debt/Mcap(x)0.040.000.000.000.02

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.